NEW CLINICAL TRIALS AVAILABLE FOR MPN PATIENTS
Receive updates on the latest MPN news & events.
Find out ways you can help support MPN patients and researchers.
Two new clinical trials available for MPN patients
Click here to learn more about current clinical trials for PV, ET, and MF patients.
PRT543
This is a Phase 1 cohort,
dose-escalation study of
PRT543 inpatients with
advanced cancers who
have exhausted available
treatment options. The
purpose of this study is to
define a safe dose and
schedule to be used in the development of PRT543.
Read the full
description here
Status: Recruiting
Vactosertib
This is a 2-tiered, Phase
2, Rule-based, Intra-
patient Dose Escalation
Study to Investigate Safety
and Feasibility of
Vactosertib (TEW-7197)
in the Treatment of Anemic
Patients With Philadelphia
Chromosome-negative
MPNs (Ph-neg MPNs).
Read the full
description here
Status: Not yet recruiting
11/06/19